Tag:
MedImmune Ventures
Latest Headlines
Latest Headlines
AstraZeneca pumping $100M more into VC unit
As the biotech venture world gets more corporate, AstraZeneca ( $AZN ) has re-upped its commitment to its MedImmune Ventures group with $100 million in additional funding. The new capital brings the VC
Ambit bounces back from dropped IPO with $30M round
A day after word that Ambit Biosciences had dropped plans for an $86 million IPO, venture investors have swooped in and replenished the cancer drug developer's coffers with a $30 million equity
